Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Study Phase : Discovery
Sponsor : Galapagos
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Galapagos and Ryvu Announce Research Collaboration
Details : In this joint reaserch collaboration, Ryvu is responsible for early drug discovery. Galapagos will have an exclusive option to license IP developed by Ryvu.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 16, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Highest Development Status : Discovery
Sponsor : Galapagos
Deal Size : Undisclosed
Deal Type : Licensing Agreement